CURSARO, CARMELA
 Distribuzione geografica
Continente #
NA - Nord America 2.436
AS - Asia 1.370
EU - Europa 757
SA - Sud America 179
AF - Africa 44
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 2
Totale 4.814
Nazione #
US - Stati Uniti d'America 2.352
SG - Singapore 417
CN - Cina 343
HK - Hong Kong 205
IT - Italia 195
BR - Brasile 144
VN - Vietnam 134
GB - Regno Unito 118
SE - Svezia 105
RU - Federazione Russa 86
BD - Bangladesh 67
KR - Corea 58
FI - Finlandia 51
DE - Germania 50
CA - Canada 44
FR - Francia 41
ID - Indonesia 31
IN - India 26
ZA - Sudafrica 19
MX - Messico 16
NL - Olanda 16
IQ - Iraq 15
BG - Bulgaria 14
ES - Italia 14
AR - Argentina 13
AT - Austria 10
UA - Ucraina 10
JP - Giappone 9
PL - Polonia 9
TR - Turchia 9
IE - Irlanda 8
LT - Lituania 8
PK - Pakistan 8
AE - Emirati Arabi Uniti 7
CR - Costa Rica 6
UZ - Uzbekistan 6
DZ - Algeria 5
EG - Egitto 5
SA - Arabia Saudita 5
CL - Cile 4
JM - Giamaica 4
MA - Marocco 4
MY - Malesia 4
VE - Venezuela 4
AL - Albania 3
CH - Svizzera 3
CO - Colombia 3
CZ - Repubblica Ceca 3
EC - Ecuador 3
GE - Georgia 3
HN - Honduras 3
IL - Israele 3
JO - Giordania 3
KZ - Kazakistan 3
PT - Portogallo 3
TN - Tunisia 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BH - Bahrain 2
BO - Bolivia 2
GH - Ghana 2
KE - Kenya 2
KG - Kirghizistan 2
NI - Nicaragua 2
NP - Nepal 2
PE - Perù 2
PH - Filippine 2
PY - Paraguay 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SV - El Salvador 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
AW - Aruba 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BE - Belgio 1
BS - Bahamas 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
GD - Grenada 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
LK - Sri Lanka 1
MW - Malawi 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
RO - Romania 1
RS - Serbia 1
TH - Thailandia 1
Totale 4.790
Città #
Santa Clara 312
Ashburn 285
Singapore 231
Hong Kong 198
Chandler 166
San Jose 164
Hefei 133
Council Bluffs 126
Nyköping 91
Fairfield 77
London 66
New York 58
Seoul 55
Los Angeles 53
Helsinki 51
Beijing 48
The Dalles 46
Hanoi 40
Houston 39
Ho Chi Minh City 38
Chicago 35
Seattle 34
Woodbridge 29
Boardman 26
Milan 26
Wilmington 25
Buffalo 24
Jakarta 22
Shanghai 19
São Paulo 19
Orem 18
Cambridge 16
Dallas 15
Princeton 15
Ann Arbor 14
Montreal 14
Salt Lake City 14
Frankfurt am Main 13
Phoenix 13
Moscow 12
Sofia 12
Amsterdam 11
Denver 11
Johannesburg 11
Lauterbourg 11
Rome 11
San Diego 11
Brooklyn 10
Toronto 10
Elk Grove Village 9
Manchester 9
North Bergen 9
Oakland 9
Warsaw 9
Haiphong 8
Kent 8
Naples 8
Portsmouth 8
Redondo Beach 8
Boston 7
Paris 7
Reggio Emilia 7
Dublin 6
Munich 6
Philadelphia 6
Secaucus 6
Tokyo 6
Atlanta 5
Boydton 5
Chennai 5
Lahore 5
Mexico City 5
Modena 5
Poplar 5
Reading 5
Rio de Janeiro 5
San José 5
Tashkent 5
Washington 5
Alexandria 4
Bologna 4
Bremen 4
Changchun 4
Columbus 4
Dhaka 4
Dubai 4
Düsseldorf 4
Miami 4
Mumbai 4
New Delhi 4
Ottawa 4
San Francisco 4
Stockholm 4
Baghdad 3
Belo Horizonte 3
Cairo 3
Campinas 3
Cavarzere 3
Cleveland 3
Curitiba 3
Totale 3.051
Nome #
X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis 280
Adefovir dipivoxil for wait-listed and post-liver transplantation patients with lamivudine-resistant hepatitis B: Final long-term results 277
Predictors of solid extra-hepatic non-skin cancer in liver transplant recipients and analysis of survival: a long-term follow-up study 259
Quality of life of hepatitis B virus surface antigen-positive patients with suppressed viral replication: comparison between inactive carriers and nucleot(s)ide analog-treated patients 225
Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis 224
Add-on peginterferon alfa-2a to nucleos(t)ide analogue therapy for Caucasian patients with hepatitis B ‘e’ antigen-negative chronic hepatitis B genotype D 213
Quality of life in liver transplant recipients during the Corona virus disease 19 pandemic: A multicentre study 204
Virological Treatment Monitoring for Chronic Hepatitis B 201
Investigating Acute Hepatitis after SARS-CoV-2 Vaccination or Infection: A Genetic Case Series 201
Itching for Answers: A Comprehensive Review of Cholestatic Pruritus Treatments 200
Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis 199
Indomethacin increases 2′,5′-oligoadenylate synthetase release by cultured liver tissue of patients with HCV chronic active hepatitis 191
Serum hepatitis B core-related antigen is an effective tool to categorize patients with HBeAg-negative chronic hepatitis B 188
Treatments for hbv: A glimpse into the future 180
Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055)) 179
Virus-specific immune response in HBeAg-negative chronic hepatitis B: relationship with clinical profile and HBsAg serum levels 179
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 179
Impact of etiology of cirrhosis on the survival of patients diagnosed with hepatocellular carcinoma during surveillance 173
Hepatitis B virus reactivation among hepatitis C patients treated with direct-acting antiviral therapies in routine clinical practice 171
Severe acute respiratory syndrome coronavirus-2-associated cholangiopathies 168
Interferon-α plus indomethacin combined therapy in HBeAg positive chronic hepatitis B non-responder to a previous IFNα course: Results of a pilot study 164
Preliminary results of thymosin-α1 versus IFN-α treatment in patients with HBeAg negative and HBV-DNA positive chronic active hepatitis 157
6. A randomized controlled trial of leukocytic IFN-a vs leukocytic IFN-a plus ribavirin in chronic hepatitis C resistant to a previous recombinant or lymphoblastoid IFN treatment 151
Worsening of Serum Lipid Profile after Direct Acting Antiviral Treatment 127
Diagnostic Performance of PIVKA-II in Italian Patients with Hepatocellular Carcinoma 124
Totale 4.814
Categoria #
all - tutte 23.986
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.986


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022176 0 0 0 2 4 16 4 34 22 22 36 36
2022/2023442 47 55 45 48 38 56 12 52 68 0 12 9
2023/2024295 11 18 10 39 63 33 20 36 10 7 19 29
2024/20251.132 30 6 4 65 205 156 98 67 170 94 90 147
2025/20262.008 139 87 135 245 300 152 199 99 233 186 131 102
2026/2027576 85 163 119 209 0 0 0 0 0 0 0 0
Totale 4.814